Evoke is the only FDA-approved therapy with 24-month follow-up from a clinical study, according to a news release. A full commercial release is scheduled for 2023.
Evoke uses closed-loop technology and is designedto treat trunk and/or limb pain. The device earned FDA approval in March.
